Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Virtuelle körperliche Aktivität Sitzübung - Phase 2 (V-PASE)

18. September 2026 aktualisiert von: Janice Eng, University of British Columbia

Assessing a Telehealth Seated Exercise Program on Post-stroke Balance and Mobility: A Mixed-method Design

This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment.

Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.

Studienübersicht

Detaillierte Beschreibung

The study will be a virtual 10-week multi-site, assessor-blinded, randomized controlled trial with an embedded qualitative component. The study will be conducted in real time using secure videoconferencing software (Zoom). Participants will be randomized 1:1 to a 10-week Seated Exercise group or a delayed 2-week Seated Exercise Group (Boot Camp). Seated exercise sessions will be delivered and supervised by a trained instructor.

Participants will use their own computer, laptop, or tablet for the zoom sessions. No Zoom sessions will be recorded. Caregivers will be invited to attend each exercise session to provide support and assistance but are not obliged to attend. A caregiver, friend, or family member will be required for each assessment to participate in the study.

Studientyp

Interventionell

Einschreibung (Geschätzt)

100

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • British Columbia
      • Vancouver, British Columbia, Kanada, V5Z 2G9
        • GF Strong Rehabilitation Centre
    • Manitoba
      • Winnipeg, Manitoba, Kanada
        • University of Manitoba
    • Nova Scotia
      • Halifax, Nova Scotia, Kanada
        • Nova Scotia Health
    • Ontario
      • London, Ontario, Kanada
        • Western University
    • Saskatchewan
      • Saskatoon, Saskatchewan, Kanada
        • University of Saskatchewan

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

Participants must meet the following inclusion criteria:

  • Adult (as defined by Province)
  • Chronic stroke (more than 6 months post-stroke)
  • Ability to stand up from a chair
  • Mobility impairment of lower extremity (requires a walking aid, with or without close supervision)
  • Able to safely engage in exercise and tolerate 60 minutes of exercises
  • Able to communicate in English
  • Have access to a tablet, computer, or laptop with internet and email access

Exclusion Criteria:

Participants will be excluded if they meet any of the following criteria:

  • Participating in formal exercise or rehabilitation activities
  • Participating in > 30 minutes/day of physical activity (moderate intensity)
  • Participating in another study that may affect outcomes to this study
  • Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software
  • A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer)
  • Clinically diagnosed with acute/chronic illness or other condition which has known physical activity contraindications or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: 10-week group

Will receive a 10-week seated exercise program, occurring 3 times per week. Sessions will be 60 minutes in duration.

The seated exercise program includes a variety of upper and lower limb strengthening, core strengthening, agility (fast arm and leg movements), and flexibility exercises. Participants will be supervised during each session thru videoconferencing by a trained instructor.

Kein Eingriff: Delayed 2-week group (Boot Camp)

The Boot Camp group will complete a 2-week seated exercise program following the 10-week active trial period.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
30 Second Sit-to-Stand
Zeitfenster: Immediately post-intervention (following 10-week trial)

Assessment of balance and lower extremity strength.

Immediately post-intervention (following 10-week trial)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Timed Up and Go
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

Participants stand up from a chair, walk 3 metres, turn around and then sit back down. The TUG assesses balance, mobility and turning ability

Immediately post-intervention, and retention (2-months post-intervention)
Tandem Stance
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

Measures balance in standing as reported in the Short Physical Performance Battery Protocol

Immediately post-intervention, and retention (2-months post-intervention)
Modified Telehealth Fugl-Meyer
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

The modified virtual Fugl-Meyer assess lower extremity impairments in those with stroke

Immediately post-intervention, and retention (2-months post-intervention)
Stroke Impact Scale
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

A self-reported measure of stroke-related disability. There are 8 domains with each item rated using a 5-point Likert scale, where lower scores mean greater difficulty to complete the item.

Immediately post-intervention, and retention (2-months post-intervention)
Activities-Specific Balance Confidence (ABC)
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

The ABC scale is a 16-item questionnaire where a participant rates their confidence in performing activities from 0% to 100% (higher percentages indicate greater self-efficacy).

Immediately post-intervention, and retention (2-months post-intervention)
Fatigue Severity Scale
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

Questionnaire assessing the impact of fatigue on daily tasks and activities. There are 9 questions, each scored from 1 to 7 (1 = strongly disagree; 7 = strong agreement).

Immediately post-intervention, and retention (2-months post-intervention)
Quality of Life (EQ-5D-5L)
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

The EQ-5D-5L assess self-care, mobility, depression/anxiety, pain, and usual activities. Each is scored with 5 levels (1=no problems, 5=major problems). Overall health on the day is scored from 0% (worst health) to 100% (best health).

Immediately post-intervention, and retention (2-months post-intervention)
Patient Health Questionnaire-4 (PHQ-4)
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

The PHQ-4 focuses on depression and anxiety. Questions are scored from 0 to 3 (0=not at all; 3 = Nearly every day).

Immediately post-intervention, and retention (2-months post-intervention)
Montreal Cognitive Assessment scale (MoCA-BLIND)
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

The MoCA-BLIND assess six different cognitive domains (excludes visual stimulus) over the phone: memory, attention, language, abstraction, delayed recall, and orientation. The MoCA-BLIND is scored from 0-22 (22 = no cognitive impairments).

Immediately post-intervention, and retention (2-months post-intervention)
Lipid Profiles
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
Fasting Glucose
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
Glucose (HbA1c)
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
30 Second Sit-to-Stand
Zeitfenster: Retention (2-months post-intervention)

Assessment of balance and lower extremity strength.

Retention (2-months post-intervention)

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Feasibility Indicator: Compliance
Zeitfenster: Through study completion (approximately 10 weeks)

Percentage of participants that attend exercise sessions.

Through study completion (approximately 10 weeks)
Feasibility Indicator: Safety
Zeitfenster: Through study completion (approximately 10 weeks)

Number of adverse events that occur during assessments or exercise sessions.

Through study completion (approximately 10 weeks)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

11. Oktober 2023

Primärer Abschluss (Geschätzt)

31. Dezember 2026

Studienabschluss (Geschätzt)

31. März 2027

Studienanmeldedaten

Zuerst eingereicht

17. Januar 2023

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

1. Februar 2023

Zuerst gepostet (Tatsächlich)

13. Februar 2023

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

23. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

18. September 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren